Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

T. Kielstein, Jan; Beutel, Gernot; Fleig, Susanne; Steinhoff, Jürgen; Meyer, Tobias; Hafer, Carsten; Kuhlmann, Uwe; Bramstedt, Jörn; Panzer, Ulf; Vischedyk, Martin; Busch, Veit; Ries, W; Mitzner, Steffen; Mees, Stefan; Stracke, Sylvia; Nürnberger, Jens; Gerke, Peter; Wiesner, Monika; Sucké, B; Abu-Tair, Miriam; Kribben, Andreas; Klause, Norbert; Schindler, Ralf; Merkel, Frank; Schnatter, Sabine; M. Dorresteijn, Eiske; Samuelsson, Ola; Brunkhorst, R.

doi:10.1093/ndt/gfs394

Public

Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

Published in Nephrology Dialysis Transplantation • Oct 1, 2012

Authors:

Jan T. Kielstein

Gernot Beutel

Susanne Fleig

Abstract

BACKGROUND: May 22nd marks the beginning of a Shiga-toxin-producing Escherichia coli (STEC) O104:H4 outbreak in Northern Germany. By its end on 27 July, it had claimed 53 deaths among 2987 STEC and 855 confirmed haemolytic-uraemic syndrome (HUS) cases. METHODS: To describe short-term effectiveness o...

Subject

Medicine

Haemolytic-uraemic syndrome

Eculizumab

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!